Cogent Biosciences, Inc. (COGT) Operating margin 2018–2021
Cogent Biosciences, Inc. (COGT) operating margin by fiscal year — reported operating income divided by reported revenue.
-959.9%FY2021 · since FY2018: -430.7% → -959.9%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2021 | -959.9% | -594.5 pp |
| FY2020 | -365.3% | -34.8 pp |
| FY2019 | -330.6% | +100.1 pp |
| FY2018 | -430.7% | — |
Operating margin = reported operating income ÷ reported revenue for the same fiscal year. Operating-loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More COGT financial trends
COGT RevenueCOGT Net incomeCOGT Net marginCOGT Gross profitCOGT Gross marginCOGT Operating incomeCOGT Operating cash flowCOGT Free cash flowCOGT Capital expendituresCOGT Return on equityCOGT Stock buybacksCOGT Dividends paidCOGT Total assetsCOGT Total liabilitiesCOGT Shareholders’ equityCOGT overview →